CAS RN: 2757082-56-5
1,8-Naphthyridine, 2-[(4R)-4-(1,1-dimethylethyl)-4,5-dihydro-2-oxazolyl]-
Product Availability
Choose a grade to view its available package options.
4 package records 3 with current stock 1 grade group
Grade
98% 99%ee (4)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260610
100mg
In stock
Shanghai Inquiry
Batchno.20260307
100mg / 250mg
Out of stock
5-7 business days Inquiry
Batchno.20260203
1g
In stock
Shenzhen, Tianjin, Wuhan, Chengdu Inquiry
Batchno.20260121
250mg
In stock
Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2757082-56-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shenzhen
Inquiry
2757082-56-5 / 4-tert-butyl-2-(1,8-naphthyridin-2-yl)-4,5-dihydro-1,3-oxazole
Standard CAS: 2757082-56-5
Multi CAS: Yes
Basic Information
copy
CAS
2757082-56-5 copy
Multi CAS
Yes copy
Molecular Formula
C15H17N3O copy
Molecular Weight
255.310000 copy
Exact Mass
255.137162 copy
InChI
InChI=1S/C15H17N3O/c1-15(2,3)12-9-19-14(18-12)11-7-6-10-5-4-8-16-13(10)17-11/h4-8,12H,9H2,1-3H3 copy
InChIKey
JVJLNFRXYYATTD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
19 copy
Aromatic heavy atom count
10 copy
Fraction Csp3
0.4 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
Molar refractivity
75.27 copy
TPSA
47.37 copy
LogP / Solubility
WLOGP
2.82 copy
MLOGP
2.49 copy
XLogP3
3.1 copy
Consensus LogP
2.8 copy
Log S (ESOL)
-3.52 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.69 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.78 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.27 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy